HCC CONNECT is an international group of experts in the field of hepatocellular carcinoma and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients.
HCC CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Bayer, AstraZeneca and from Eisai Europe Limited.
What’s new from HCC CONNECT
Podcast
Episode
1
of 1
HCC podcast series part 4: Intermediate HCC – the evolving role of IO
Integrating multimodal approaches with multidisciplinary care
Experts
Sally Jenkins, Prof. Dr Ángel Cequier Fillat, Prof. Gilles MontalescotEndorsed by
-
MIN
-
Aug 2024
Publication
Surveillance and Diagnosis of HCC in Asia: Poster Presentation at ILCA 2023
Data from an Asia-Pacific patient and HCP survey
Experts
Prof. Chee-Kiat Tan-
Downloadable
Resources -
5 MIN
-
Sep 2023
Podcast
A New Era in Treating Patients with Advanced HCC
2nd line treatment selection and the right time to switch
Experts
Prof. Dr Jeroen Dekervel, Dr Amit SingalEndorsed by
-
Downloadable
Resources -
29 MIN
-
Aug 2023
Micro learning
Module
2
of 2
The Use of Immunotherapy in HCC: In-depth Subgroup Analyses and Challenges
Module 2 of the Immunotherapy in HCC micro learning
Experts
Prof. Dr Peter R. Galle, Dr Aiwu Ruth HeEndorsed by
-
Downloadable
Resources -
4 MIN
-
Jun 2023
Video
Episode
4
of 4
Treatment Options for HCC Patients Not Eligible for or Progressed on Immunotherapy – Episode 4
Panel Discussion and Summary
Experts
Prof. Michel Ducreux, Dr Timon Vandamme, Asst. Prof. Changhoon YooEndorsed by
-
Downloadable
Resources -
15 MIN
-
Jun 2023
Video
Episode
3
of 4
Treatment Options for HCC Patients Not Eligible for or Progressed on Immunotherapy – Episode 3
Overview of 2nd line treatment options in advanced HCC
Experts
Prof. Michel Ducreux, Dr Timon Vandamme, Asst. Prof. Changhoon YooEndorsed by
-
14 MIN
-
Jun 2023
